StemCells Inc. Provides Update on NCL Program Meeting with FDA

»

18 November 2009 8:35 AM ( 82 days ago)
StemCells, Inc. today provided an update on the ongoing clinical development program of its proprietary HuCNS-SC® product candidate for neuronal ceroid lipofuscinosis , often referred to as Batten disease. On November 6, 2009, representatives of StemCells, Inc. met with the U.S...
stemcells inc
To comment or read log in. No account? Register free.




 submit 'StemCells Inc. Provides Update on NCL Program Meeting with FDA' on facebook   submit 'StemCells Inc. Provides Update on NCL Program Meeting with FDA' to digg   submit 'StemCells Inc. Provides Update on NCL Program Meeting with FDA' to Stumbleupon
Comments
No one has commented on this article yet.